Clinical Trial Update: Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on TC011 for relapsed or refractory follicular lymphoma, noting the study status as not yet recruiting and reporting on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• TC011

Snippet

Sponsor: TICAROS Co., Ltd. | Conditions: Follicular Lymphoma (FL) | Phase 2 | Status: NOT_YET_RECRUITING